| Аудиторские |  Игры |  Промышленность |  Торговля |  Нефтеные |  Строительство |  Трейдеры |  Инвестиционные |  Юридические |  Оффшорные |  Автомобили |  Страхование |  Комуникации |  Химические компании |  Программы | 
 
Vertex Pharmaceuticals, Incorporated (NASDAQ: VRTX)

Price and Chart delayed at least 15 mintues.
Price $ 33.95 Change 0.00
Open 0.00 % Change 0.0%
Prev Close 33.95 Volume NA
Market Value 6 bil P/E Ratio NA
Bid 31.11 EPS -3.59
Ask 34.03 Dividend 0.00
High 0.00 Yield 0.0
Low 0.00 Shares Out 173 mil
52wk High 36.30 52wk Low 18.43
Industry: Drug Manufacturers - Other
Sector: Healthcare

VRTX Profile

The Company is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Vertex Pharmaceuticals, Inc.
130 Waverly Street
Cambridge, MA 02139-4242
Phone: (617) 444-6100
Fax: (617) 444-6680
Web Site: www.vpharm.com

VRTX Wires Headlines

06.12.09  Thomas Weisel analyst rates Idenix 'Overweight'
06.10.09  Vertex sees profit soon after hep C drug launch-CEO
06.08.09  BRIEF-Vertex to exchange $40.2 mln of senior notes into common stock
06.08.09  Vertex swaps $103.3 million in notes for stock
06.08.09  BRIEF-Vertex Pharmaceuticals to exchange $103.3 mln senior notes into common stock

More VRTX From Wires Headlines >

Forbes.com on VRTX     RSS

    No news found in the past 30 days.

    VRTX Press Releases

    06.23.09  Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2009 Piper Jaffray Europe...
    06.08.09  Vertex Pharmaceuticals Announces Agreements to Exchange an Additional $40.2 Million of its 2013...
    06.08.09  Vertex Pharmaceuticals Announces Agreements to Exchange $103.3 Million of its 2013 Convertible...

    More VRTX Press Releases >

    VRTX Ratios & Returns

    Price-to-sales 37.31
    Return on Equity 0.0
    Operating Margin 0.0
    Profit Margin 0.0%

    More VRTX Ratios & Returns >

    VRTX Financials

    Sales 157.808 mil
    Profits -526.369 mil
    Assets $1.565883 bil
    Employees 1310.0
Vertex Pharmaceuticals is ranked # 1990 on the 2009 Forbes 2000 List

A D V E R T I S E M E N T




СМОТРЕТЬ
презентацию